Lianhe Chemical Technology

What Lianhe Chemical Technology does

Lianhe Chemical Technology Co., Ltd. ('Lianhetech') is a China-headquartered, Shenzhen-listed (Stock Code: 002250, since 2008) Contract Development and Manufacturing Organization (CDMO) founded in 1985. The company provides integrated chemistry-based services across the full product lifecycle — from synthetic route design, process development, and analytical/regulatory support to kilo-lab piloting, scale-up, and commercial manufacturing — for global agrochemical, pharmaceutical, and performance chemicals customers. Operations are organized into four Business Units: Crop Protection (intermediates, advanced intermediates, and active ingredients for global agrochemical OEMs), Pharmaceuticals (GMP-compliant synthesis route design through commercial API supply), Performance Chemicals (dyestuffs and pigments, polymers, paper, care chemicals, cement additives, LCD/LED and battery chemicals), and Equipment & Engineering Services (via wholly-owned subsidiary Shanghai Baofeng Machinery Manufacturing, producing HVAC equipment and pressure vessels). Supporting capabilities include Innovation & Technology, Process Development, Project Management (with a PMO), Regulatory Support (REACH, substance declarations, import/export approvals), and Quality Management (ISO 9001 since 2000).

Underlying technology and infrastructure include 3 R&D centers (Shanghai, Jiangkou, and Songjiang CRO Lab opened 2023), 13 production sites across China (Taizhou HQ, Shanghai, Jiangkou, Duqiao, Linhai under construction, Jiangsu, Xincai, Dezhou, Fuxin, Hubei, Yancheng), the UK (Seal Sands, Middlesbrough — acquired via Fine Industries in 2017), and Malaysia (construction started 2024). Manufacturing assets span reactors from 20L to 25,000L, continuous flow reactors, class D clean rooms for API production, cryogenic reaction capability down to -80°C, and an in-house engineering team that builds custom equipment. Certifications include US FDA cGMP (Jiangkou passed with zero observations, March 2017), German/EU GMP, China GMP, ISO 9001, OHSAS 18001, and Chinese Veterinary Drug GMP (2016). Over 100 scientists and technicians support customers across stages, and National Enterprise Technology Center status was approved in 2016.

Lianhetech makes money through B2B project-based CDMO contracts with global enterprise OEMs in crop protection, pharma, and performance chemicals, plus hardware sales from the Baofeng equipment subsidiary. Pricing is negotiated on a per-project basis and not publicly disclosed. Go-to-market combines dedicated BU-aligned direct sales teams, regular participation in international exhibitions (CPhI events across Japan, China, Worldwide, plus Chemspec Europe, InformEx USA, and Specialty & Agrochemicals America), regional offices in China, the UK, Japan (opened 2024), and Luxembourg, and an active Business Development function pursuing technology licensing, partnerships, and M&A with multinationals, start-ups, and research institutes. Leadership is anchored by Chairwoman & President Maggie Wang (founder's successor; transitioned to Chairwoman-only in 2017) and Dr. Andreas Winterfeldt (President from 2017, SVP Pharma BU, National 1000 Talents Program).

Name

Lianhe Chemical Technology

Legal name

Lianhe Chemical Technology Co., Ltd.

Website

https://lianhetech.com

Company type

Public

Founded year

1985

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Lianhe Chemical Technology (Lianhetech) is a China-headquartered, Shenzhen-listed CDMO providing integrated chemistry-based contract development and manufacturing — from R&D through commercial production — to global agrochemical, pharmaceutical, and performance chemicals customers across 13 production sites.

Ownership category

akta.pro rank

Product category

Chemical Contract Manufacturing (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Boiler, Tank, and Shipping Container Manufacturing (3324)

SIC

Miscellaneous Chemical Products (2890), General Industrial Machinery & Equipment, Nec (3569)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

Keywords

• Contract development manufacturing
• Pharmaceutical intermediate manufacturing
• Agrochemical contract manufacturing
• Custom chemical synthesis
• API process development

Headquarters

HQ city

Taizhou

HQ country

China

HQ region

Asia

Offices20 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Development & Manufacturing (CDMO) Services: Lianhetech provides integrated chemical solutions from laboratory scale to commercial product supply under a CDMO model. Services span synthetic route design, process development, scale-up manufacturing, and process optimization for customers in Crop Protection, Pharmaceuticals, and Performance Chemicals. Revenue is generated through long-term contract manufacturing relationships with global agrochemical and pharmaceutical companies.
2. Equipment & Engineering Services: Through wholly-owned subsidiary Shanghai Baofeng Machinery Manufacturing Co., Ltd., Lianhetech provides HVAC equipment manufacturing and engineering services including evaporative condensers, closed cooling towers, thermo siphon evaporators, air coolers, refrigeration units, and 1st and 2nd class pressure vessels.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

Lianhetech is a Contract Development and Manufacturing Organization (CDMO) that provides integrated chemistry-based services from laboratory route design and process development through kilo-lab, pilot, and commercial-scale manufacturing for global agrochemical, pharmaceutical, and performance chemical customers. Its four Business Units (Crop Protection, Pharmaceuticals, Performance Chemicals, and Equipment & Engineering via subsidiary Shanghai Baofeng) deliver custom synthesis, intermediates, advanced intermediates, and active ingredients supported by regulatory, quality, and project management capabilities across 13 production sites and 3 R&D centers in China, the UK, Malaysia, and Japan.

Product overview

Lianhe Chemical Technology (Lianhetech) is a leading Contract Development and Manufacturing Organization (CDMO) providing chemistry solutions and technology services. The company operates through four Business Units: Crop Protection, Pharmaceuticals, Performance Chemicals, and Equipment & Engineering Services (via subsidiary Baofeng). These are supported by five core capabilities: Innovation & Technology, Process Development, Project Management, Regulatory Support, and Quality Management. The company offers integrated services from R&D and pilot scale through commercial manufacturing, serving global agrochemical, pharmaceutical, and specialty chemical markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Crop Protection CDMO
• Pharmaceuticals CDMO
• Performance Chemicals CDMO
• Equipment & Engineering Service (Shanghai Baofeng)
• Contract Research (CRO) Services

Quantifiable outcome

• Successfully passed US FDA cGMP inspection at Jiangkou site with zero observations (March 2017)
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and moderate.

• CPCIF RCC (China Petroleum and Chemical Industry Federation Responsible Care Committee)coreStrategic or Co-development Partner · 19 April 2019Lianhetech actively participates in and supports the Responsible Care initiative of the global chemical industry. The company has won multiple Responsible Care awards from CPCIF RCC and ICCA RCLG, including Best Practice Units, Excellent Leaders, and Excellent Promoters awards in 2019. Lianhetech serves as deputy director unit of CPCIF.RCC, deputy group leader of community awareness & emergency response group and product safety group.
• ICCA RCLG (International Council of Chemical Associations Responsible Care Leadership Group)coreStrategic or Co-development Partner · 19 April 2019Lianhetech participates in joint award programs with ICCA RCLG, winning multiple Responsible Care awards for Best Practice Units, Excellent Leaders, and Excellent Promoters.
• AICM (Association of International Chemical Manufacturers)moderateStrategic or Co-development Partner · 19 April 2019Co-sponsored the China Responsible Care Promotion Conference 2019 with CPCIF, bringing together over 40 enterprises for Responsible Care promotion.
• China Petroleum and Chemical Industry Association (CPCIF) Emergency Response GroupmoderateStrategic or Co-development Partner · 25 October 2016Lianhetech (Yancheng) Co., Ltd jointly hosted the Emergency Response working conference with the association. Lianhetech serves as deputy head of the Emergency Response Group (BASF serves as head). Lianhetech demonstrated safety management capabilities through emergency response drills.
• Fine Industries Limited (now Fine Organics Ltd. & Fine Environmental Services Ltd.)coreStrategic or Co-development PartnerAcquired in 2017 from NorthEdge Capital and management. Fine Industries Group operates an FDA inspected site at Seal Sands, UK with around 220 employees and revenues exceeding $60 million. Provides complex intermediates and actives for agrochemical and pharma clients, and specialty chemicals solutions. The acquisition was completed in July 2017.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Recipharm: European CDMO focused on small-molecule drug substance and drug product manufacturing — comparable service offering to Lianhetech's pharma CDMO, with similar global-pharma customer focus.
• Lonza Group: Swiss global CDMO leader across small molecules, biologics, and cell & gene therapy — overlaps with Lianhetech on small-molecule API/intermediates as part of a much broader portfolio serving global pharma.
• Catalent: Global CDMO offering small-molecule drug substance and drug product services plus biologics — overlaps with Lianhetech's integrated pharma CDMO but at much larger scale and broader modality coverage.
• BASF: Global chemical giant with significant agrochemical and pharma custom manufacturing operations — overlaps with Lianhetech's Crop Protection and Performance Chemicals BUs as a much broader incumbent with in-house CDMO capabilities.

Direct peers

• Porton Pharma Solutions: Chinese small-molecule CDMO with API and intermediate manufacturing, GMP sites in China and the US — directly competes with Lianhetech on small-molecule API CDMO contracts from global pharma.
• WuXi AppTec: Largest Chinese CRDMO/CDMO with WuXi STA division providing small-molecule API and intermediate CDMO services to global pharma — directly comparable to Lianhetech's Pharmaceuticals BU and a key competitor for the same Western pharma outsourcing contracts.
• Jiuzhou Pharmaceutical: Zhejiang-based Chinese CDMO focused on small-molecule APIs, intermediates, and formulation services for regulated markets — directly comparable to Lianhetech's pharma CDMO BU and a regional peer.
• Asymchem Laboratories: Shenzhen- and Tianjin-based pure-play small-molecule API/intermediate CDMO serving global pharma and biotech — directly comparable in service offering, regulatory certifications, and target customer base to Lianhetech's pharma CDMO.
• Siegfried Holding: Swiss pure-play small-molecule API CDMO with global sites serving branded and generic pharma — directly comparable in service offering, regulatory positioning, and pharma customer base.

Regional players

• Shandong Xinhua Pharmaceutical: Shandong-based Chinese manufacturer of APIs and intermediates for pharma, including CDMO-style services — comparable product/customer base to Lianhetech's pharma BU, primarily serving domestic and Asian customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lianhe-chemical-technology

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lianhe Chemical Technology